Grant: Project Grant
Université Laval
$191,250.00
Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors
FY 2018-19
Summary
Context: Adjuvant endocrine therapy (AET) is an oral medication prescribed to women with hormone-sensitive breast cancer (75% of cases) to reduce recurrence and mortality risks. Suboptimal AET adherence is common: 31% to 47% of women do not persist with AET for the 5 years minimally recommended. Few AET adherence-enhancing interventions were evaluated and their results were inconclusive. The rigorous development and testing of innovative approaches is thus urgently needed. To optimize AET adherence, we have designed a community pharmacy-based program, the PAcHA program (programme en Pharmacie pour l'ACcompagnement des femmes ayant de l'Hormonothérapie Adjuvante). The program and study procedures will be pilot-tested before the conduct of a full-scale study to assess its efficacy.
Objectives: This pilot study will evaluate: 1) the effect of PAcHA on factors expected to influence AET adherence; 2) program acceptability; 3) program implementation; and 4) feasibility of procedures for conducting a full-scale study.
Methods: We will conduct a randomized controlled pilot study. Pharmacists working in pharmacies assigned to the PAcHA group (33 pharmacies) will receive a web-based training and manuals to use during their counselling with women having an AET. Those in pharmacies assigned to the control group (n=33) will provide usual care. Preliminary effects of the program and the experience of pharmacists and women with the program will be evaluated using questionnaires, interviews and pharmacy records. Contributions: Pilot study results will provide crucial information on the potential of this first community pharmacy-based program designed to enhance AET adherence. Results will be used to optimize the program and plan a study to assess its effects on adherence. If effective, this program has the potential to fill a gap in breast cancer support care and optimize the benefits of a drug largely prescribed.
Department
Program
Project Grant
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
402816
Name
Lauzier Sophie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Services Evaluation & Interventions Research 2
Projecttitle
Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$191,250
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Adherence To Treatment; Adjuvant Endocrine Therapy; Breast Cancer; Community Pharmacy; Feasibility Study; Intervention Evaluation; Pilot Study; Randomized Controlled Trial; Support; Survivorship
Abstract
Context: Adjuvant endocrine therapy (AET) is an oral medication prescribed to women with hormone-sensitive breast cancer (75% of cases) to reduce recurrence and mortality risks. Suboptimal AET adherence is common: 31% to 47% of women do not persist with AET for the 5 years minimally recommended. Few AET adherence-enhancing interventions were evaluated and their results were inconclusive. The rigorous development and testing of innovative approaches is thus urgently needed. To optimize AET adherence, we have designed a community pharmacy-based program, the PAcHA program (programme en Pharmacie pour l'ACcompagnement des femmes ayant de l'Hormonothérapie Adjuvante). The program and study procedures will be pilot-tested before the conduct of a full-scale study to assess its efficacy.
Objectives: This pilot study will evaluate: 1) the effect of PAcHA on factors expected to influence AET adherence; 2) program acceptability; 3) program implementation; and 4) feasibility of procedures for conducting a full-scale study.
Methods: We will conduct a randomized controlled pilot study. Pharmacists working in pharmacies assigned to the PAcHA group (33 pharmacies) will receive a web-based training and manuals to use during their counselling with women having an AET. Those in pharmacies assigned to the control group (n=33) will provide usual care. Preliminary effects of the program and the experience of pharmacists and women with the program will be evaluated using questionnaires, interviews and pharmacy records. Contributions: Pilot study results will provide crucial information on the potential of this first community pharmacy-based program designed to enhance AET adherence. Results will be used to optimize the program and plan a study to assess its effects on adherence. If effective, this program has the potential to fill a gap in breast cancer support care and optimize the benefits of a drug largely prescribed.
Competitiondate
201903
Approvedterm2
2 yrs 5 mths
Pinamesdelim
Lauzier, Sophie
Approvedterm
2 ans 5 mois
Cihrcontribution2
~ $191,250~ $0~